Tertatolol
From Wikipedia, the free encyclopedia
 |
|
|
Tertatolol
|
|
| Systematic (IUPAC) name | |
| 1-(tert-Butylamino)-3-thiochroman-8-yloxypropan-2-ol | |
| Identifiers | |
| CAS number | |
| ATC code | C07 |
| PubChem | |
| Chemical data | |
| Formula | C16H25NO2S |
| Mol. mass | 295.44 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Tertatolol is a medication in the class of beta blockers, used in the treatment of high blood pressure. It was discovered by the French pharmaceutical company Servier.
[edit] External links
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||
